Fidelity Investments’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Fidelity Investments’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,318,727	Closed	-$48M	–	2768
2016 Q4	$48M	Buy	1,318,727 +535,331	+68%	+$18.9M	0.01%	1316
2016 Q3	$29.9M	Buy	783,396 +715,619	+1,056%	+$10.6M	﹤0.01%	1508
2016 Q2	$554K	Buy	+67,777	New	+$455K	﹤0.01%	2536

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Fidelity Investments's CLCD Position: Q1 2017 in Review

Fidelity Investments sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 1,318,727 shares — an estimated $48M sold.

Fidelity Investments first reported a position in CLCD in Q2 2016 and held it in 3 quarters. The position peaked at $48M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Fidelity Investments reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Fidelity Investments sold 1,318,727 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $48M.
Fidelity Investments first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
Fidelity Investments's CoLucid Pharmaceuticals, Inc. position peaked at $48M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.